Dividend Power Score
A single, comprehensive score designed to measure the true strength of a company’s dividend.
This score combines three essential pillars of dividend quality:
Consistency – Measures how reliable the dividend has been over time, focusing on payment history, stability, and the absence of cuts or suspensions.
Payability – Assesses the company’s financial ability to sustain its dividend, taking into account cash flow, earnings coverage, balance sheet strength, and overall financial health.
Growth – Evaluates the long-term growth of both the dividend and the company’s share price, highlighting businesses that consistently increase payouts while creating shareholder value.
Higher scores identify companies that have historically delivered dependable income alongside sustained dividend growth and long-term capital appreciation.
Company Overview
ADM Tronics Unlimited, Inc. is a U.S.-based technology and manufacturing company operating primarily in the medical device, healthcare, electronics, and biotechnology industries. The company focuses on the development, manufacture, and commercialization of electronic and medical technologies, with an emphasis on diagnostic, therapeutic, and regenerative medicine applications. ADM Tronics generates revenue through product development, contract manufacturing, licensing arrangements, and select healthcare-related services.
Founded in 1969, ADM Tronics initially focused on electronic components and systems before expanding into medical technologies and healthcare-related innovations. Over time, the company evolved into a diversified enterprise with capabilities spanning medical device engineering, bioelectronic therapies, and precision manufacturing. Its strategic positioning centers on proprietary technologies, vertically integrated manufacturing, and long-standing expertise in regulated healthcare markets.
Business Operations
ADM Tronics conducts operations through multiple business lines, including Medical Device Development, Electronic Manufacturing Services, and Biotechnology and Regenerative Medicine Research. The company designs and manufactures medical and therapeutic devices, provides contract manufacturing for third parties, and develops proprietary bioelectronic technologies. Revenue is derived from product sales, manufacturing contracts, and licensing of intellectual property.
Operations are primarily domestic, with facilities located in the United States, supporting research and development, manufacturing, and administrative functions. ADM Tronics controls specialized manufacturing assets, engineering laboratories, and regulatory-compliant production capabilities. The company operates through and alongside subsidiaries such as ADM Tronics Medical Devices, Inc., which supports its medical technology initiatives.
Strategic Position & Investments
ADM Tronics’ strategic direction emphasizes innovation in non-invasive medical technologies, regenerative medicine, and bioelectronic therapies. Growth initiatives include advancing proprietary therapeutic platforms, expanding contract manufacturing relationships, and pursuing regulatory approvals for new medical products. The company has historically invested in internal research and development rather than large-scale acquisitions.
Notable investments include continued development of wound healing, tissue regeneration, and diagnostic technologies through internal programs and subsidiaries. ADM Tronics has also maintained interests in emerging healthcare sectors where electronic and biological systems intersect, though public disclosures indicate that commercialization timelines and outcomes may vary depending on regulatory and market conditions.
Geographic Footprint
ADM Tronics’ operations are concentrated in North America, with its corporate headquarters and principal facilities located in New York, United States. The company primarily serves U.S.-based customers in the healthcare and electronics sectors, while also supporting international clients through export sales and technology licensing arrangements.
Although ADM Tronics does not maintain extensive overseas manufacturing facilities, its technologies and products have been marketed to customers in international markets, particularly where U.S.-developed medical devices and electronic systems are adopted. Its global influence is largely driven by intellectual property, contract manufacturing relationships, and cross-border distribution partnerships.
Leadership & Governance
ADM Tronics is founder-led and governed by a leadership team with long-standing involvement in the company’s strategic and technological development. The leadership philosophy emphasizes innovation, technical expertise, and long-term value creation through proprietary technologies and disciplined capital management.
Key executives include:
- Andre DiMino – Chairman of the Board, President, and Chief Executive Officer
- Marc Johnson – Chief Financial Officer
- Howard L. Safir – Director
- Robert J. Ward – Director
The company’s governance structure reflects its focus on founder leadership, continuity of management, and oversight aligned with its technology-driven business model.